Table 1 Patient characteristics.

From: Artificial intelligence system for predicting hand-foot skin reaction induced by vascular endothelial growth factor receptor inhibitors

 

N (%)

Sex

 Male

60 (64.5)

 Female

33 (35.5)

Age

 Median (range)

63 (39–83)

Performance status

 0

46 (49.5)

 1

29 (31.2)

 2

5 (5.4)

 Unknown

13 (13.9)

Cancer type

 

 Renal cell carcinoma

41 (44.1)

 Colorectal

35 (37.6)

 GIST

12 (12.9)

 Thyroid

3 (3.2)

 Soft tissue sarcoma

2 (2.2)

Type of VEGFR inhibitor

 Regorafenib

39 (41.9)

 Axitinib

20 (21.5)

 Sunitinib

11 (11.8)

 Pazopanib

11 (11.8)

 Cabozantinib

7 (7.5)

 Lenvatinib

3 (3.2)

 Sorafenib

2 (2.2)

  1. GIST: gastrointestinal stromal tumor, VEGFR: vascular endothelial growth factor receptor.
Back to article page